Results 151 to 160 of about 1,991,467 (364)

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

open access: yesMolecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia   +17 more
wiley   +1 more source

Building upon the sugar beverage tax in Mexico: a modelling study of tax alternatives to increase benefits

open access: yesBMJ Global Health, 2023
Tonatiuh Barrientos-Gutiérrez   +5 more
doaj   +1 more source

Necropsy Survey of Staphylococcal Infection on Patients Dying in Hospitals: A Report from the Public Health Laboratory Service [PDF]

open access: bronze, 1966
Ruth Baldwin   +41 more
openalex   +1 more source

Tax and Spending Policy and Economic Mobility [PDF]

open access: yes, 2008
Surveys the literature on how economic mobility is affected by federal tax policies such as the Earned Income Tax Credit and deductions for home ownership; government spending on education and health care; and income supports such as Social ...
Brenda Cushing-Daniels   +1 more
core  

MET variants with activating N‐lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

open access: yesMolecular Oncology, EarlyView.
MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Célia Guérin   +14 more
wiley   +1 more source

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial–mesenchymal transition and tumor‐infiltrating lymphocytes

open access: yesMolecular Oncology, EarlyView.
Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.
Françoise Derouane   +16 more
wiley   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

open access: yesMolecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park   +6 more
wiley   +1 more source

Demographic and health surveys and its quality in India. [PDF]

open access: yesSSM Popul Health, 2023
Acharya R   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy